Showing 2,821 - 2,840 results of 12,750 for search '"therapeutics"', query time: 0.08s Refine Results
  1. 2821
  2. 2822

    FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy by Liang Zhao, Long Sun, Kaili Fu, Qin Lin, Xiaoyuan Chen, Qicong Luo, Hua Wu, Jianhao Chen, Yangfan Zhou, Yizhen Pang, Guoqiang Su, Haojun Chen

    Published 2025-01-01
    “…Both 68Ga-DOTA-2P(FAPI)2 and 177Lu-DOTA-2P(FAPI)2 radiopharmaceuticals significantly improved therapeutic outcomes when combined with anti-PD-L1 monoclonal antibody (αPD-L1 mAb). …”
    Get full text
    Article
  3. 2823
  4. 2824
  5. 2825

    Digital health technologies for metabolic disorders in older adults: a scoping review protocol by Michael Brändle, Elgar Fleisch, Tobias Kowatsch, Panitda Huynh, Mia Jovanova

    Published 2024-12-01
    “…Digital health technologies (DHTs), such as patient monitoring, digital diagnostics and digital therapeutics, emerge as promising tools for health promotion in day-to-day life. …”
    Get full text
    Article
  6. 2826
  7. 2827
  8. 2828

    Targeted Sonodynamic Therapy Platform for Holistic Integrative Helicobacter pylori Therapy by Xiaojing Yin, Yongkang Lai, Xinyuan Zhang, Tingling Zhang, Jing Tian, Yiqi Du, Zhaoshen Li, Jie Gao

    Published 2025-01-01
    “…The increase in resistance to antibiotics, along with the adverse effects caused by complicated medication protocols, has made the eradication of H. pylori a more formidable challenge, necessitating alternative therapeutics. Herein, a targeted nanoplatform is reported based on sonodynamic therapy, the chitosan‐conjugated fucose loaded with indocyanine green (ICG@FCS). …”
    Get full text
    Article
  9. 2829

    Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma by Hezhou Long, Jiafu Zhou, Changxia Zhou, Shuyu Xie, Jingling Wang, Minjia Tan, Junyu Xu

    Published 2025-01-01
    “…<b>Conclusions</b>: In summary, this study conducted an in-depth analysis of the molecular alterations in proteins and phosphorylation modifications induced by clinical HCC-targeted drugs, predicting drug combination strategies and therapeutic targets.…”
    Get full text
    Article
  10. 2830

    Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations by Joel Heisler, Daniel Kovner, Saeed Izadi, Jonathan Zarzar, Paul J. Carter

    Published 2024-12-01
    “…The self-association of therapeutic antibodies can result in elevated viscosity and create problems in manufacturing and formulation, as well as limit delivery by subcutaneous injection. …”
    Get full text
    Article
  11. 2831

    Dropped Head Syndrome Treated with Physical Therapy Based on the Concept of Athletic Rehabilitation by Toshio Mori, Kentaro Mataki, Yukiyo Shimizu, Kai Matsuba, Kosei Miura, Hiroshi Takahashi, Masao Koda, Hiroshi Kamada, Masashi Yamazaki

    Published 2020-01-01
    “…., chin-on-chest deformity, and their activities of daily living are impaired considerably. However, the therapeutics for DHS, especially conservative treatment, have not been fully established. …”
    Get full text
    Article
  12. 2832

    Research Progress on the Potential Pathogenesis of Persistent Postural–Perceptual Dizziness by Chen Qin, Ruyi Zhang, Zhihui Yan

    Published 2025-01-01
    “…Conclusion Understanding the complex pathogenesis of PPPD is crucial for the development of novel therapeutics against PPPD. Following the existing findings, our review suggests directions for future research.…”
    Get full text
    Article
  13. 2833
  14. 2834

    Determination of antibacterial and antioxidant potential of organic crude extracts from Malus domestica, Cinnamomum verum and Trachyspermum ammi by Asma Irshad, Rabbia Jawad, Qudsia Mushtaq, Alexis Spalletta, Patrick Martin, Uzair Ishtiaq

    Published 2025-01-01
    “…This study has compared three potential medicinal plants with biological active and eco-friendly components which play crucial role in therapeutics.…”
    Get full text
    Article
  15. 2835

    Priming Adipose-Derived Mesenchymal Stem Cells with Hyaluronan Alters Growth Kinetics and Increases Attachment to Articular Cartilage by Peter Succar, Michael Medynskyj, Edmond J. Breen, Tony Batterham, Mark P. Molloy, Benjamin R. Herbert

    Published 2016-01-01
    “…Background. Biological therapeutics such as adipose-derived mesenchymal stem cell (MSC) therapy are gaining acceptance for knee-osteoarthritis (OA) treatment. …”
    Get full text
    Article
  16. 2836
  17. 2837

    Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy by Amelia C. McCue, Stephen J. Demarest, Karen J. Froning, Michael J. Hickey, Stephen Antonysamy, Brian Kuhlman

    Published 2024-12-01
    “…This study showcases an approach to developing immune-modulating therapeutics that prioritizes safety and has the potential to advance cancer immunotherapy treatment strategies.…”
    Get full text
    Article
  18. 2838

    CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease by Angela Todorovski, Tzu-Fei Wang, Marc Carrier, Yan Xu

    Published 2025-01-01
    “…In this review, we provide an overview of CHIP as a mediator of thromboembolic diseases and discuss emerging therapeutics aimed at intervening on this thrombo-inflammatory nexus.…”
    Get full text
    Article
  19. 2839

    Review of Atypical Organometallic Compounds as Antimalarial Drugs by Samuel K. Kwofie, Emmanuel Broni, Bismark Dankwa, Kweku S. Enninful, Joshua Teye, Cedar R. Davidson, Josephine B. Nimely, J. Chioma Orizu, Prakasha Kempaiah, Brijesh Rathi, Whelton A. Miller

    Published 2020-01-01
    “…Furthermore, recent developments in the field are discussed, and future applications of this emerging class of therapeutics in antimalarial drug discovery are suggested.…”
    Get full text
    Article
  20. 2840